top of page

NCIRE Investigators

moral-injury-compilation.jpg
Maria Wei

MD, PhD

Staff Physician, SFVAHCS; Professor of Dermatology; Director, Melanoma Surveillance Clinic, UCSF; Director, Dermatology Genetics/Familial Cancer Syndrome Clinic, UCSF

Maria L. Wei, MD, PhD, is a Professor of Dermatology at the University of California, San Francisco (UCSF) and a Staff Physician at the San Francisco VA Health Care System. She directs the UCSF Melanoma Surveillance Clinic, which cares for individuals with melanoma as well as patients at high risk for developing melanoma – a group that includes those with a family history of melanoma, those with genetic test results indicating a risk, and those with many moles or large congenital moles. She also directs the UCSF Dermatology Genetics/Familial Cancer Syndrome Clinic, which cares for individuals with pathogenic gene variants, and who have an increased risk of developing benign and cancerous skin tumors. Dr. Wei also sees patients with pigmentary disorders such as melasma and vitiligo, as well as general dermatology patients.


Wei leads a research laboratory that studies skin disorders that result from and are affected by the intersection of genetics, the environment and behavior. One focus of study is the aggressive skin cancer melanoma; her group is developing novel non-invasive methods for skin cancer screening and diagnosis, using artificial intelligence and machine learning methods, and also studies factors that affect melanoma outcomes. Another area of study is assessing the effects of air pollution on inflammatory skin disorders such as atopic dermatitis and psoriasis.

moral-injury-compilation.jpg
Mark Ratcliffe

MD

Staff Physician, Chief of Surgery, SFVAHCS

Professor and Vice-Chair of Surgery, UCSF

Dr. Ratcliffe was the first cardiac surgeon to use realistic mathematical models to evaluate the efficacy of novel surgical procedures for the treatment of heart failure and ischemic heart disease. He also mathematically analyzed surgical anterior ventricular restoration (SAVER), another surgical treatment for heart failure, and determined the circumstances under which it can be used most effectively.

moral-injury-compilation.jpg
Mary A. Whooley

MD, FACP, FAHA, FACC

Primary Care Physician, SFVAHCS

Professor of Medicine, Epidemiology and Biostatistics, UCSF

Dr. Whooley’s research focuses on understanding the links between mental and physical health, particularly depression and cardiovascular disease. In 1997, she validated a 2-question screening instrument (now known as the Patient Health Questionnaire (PHQ-2) yes/no version) for depression in primary care patients. Since then, numerous managed care organizations have adopted the PHQ-2 yes/no version to aid in the detection of depression.

moral-injury-compilation.jpg
Mehrdad Arjomandi

MD

Professor of Medicine, UCSF

Assistant Professor in residence, SFVAHCS

Director of Environmental Medicine Clinic, SFVAHCS

Director of the UCSF Human Exposure Laboratory at San Francisco General Hospital


Dr. Arjomandi's research activities are focused on understanding the physiologic and immunologic mechanisms via which environmental exposures contribute to chronic lung disease and how knowledge of these mechanisms could be translated to ways to better define, prognosticate, and manage disease burden.


His research efforts are dedicated to (1) investigate the biology of airway immune cells using inhalational exposure to ozone in humans as a model of lung injury simulating exacerbation in chronic lung disease, and (2) characterize the cardiopulmonary abnormalities in a cohort of individuals with history of prolonged heavy exposure to secondhand tobacco smoke as a model of occult chronic obstructive lung disease.


moral-injury-compilation.jpg
Michael G. Shlipak

MD, MPH

Associate Chief of Medicine for Research Development, SFVAHCS

Professor of Medicine, Epidemiology and Biostatistics, UCSF

Co-Founder and Scientific Director, Kidney Health Research Collaborative



Dr. Shlipak, MD, MPH is a Co-Founder and Scientific Director of the Kidney Health Research Collaborative, a joint program of UCSF, NCIRE and the SFVAHCS. His research activities have the overall objection of improving our understanding of the determinants of kidney disease and our ability to detect, diagnose and treat kidney disease. Recently, he has been primarily focused upon building a diagnostic panel for kidney disease that would change how clinicians treat kidney disease.

2026-2027 NAVREF Membership Badge.png

© 2025 NCIRE. For more information please call us at (415) 750-6954
NCIRE is a 501(c)3 nonprofit research institute and all gifts are tax deductible (Tax ID #94-3084159)

GPTW2026.png
NCIRE Pronunciation
bottom of page